Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2323]
News [5452]
Articles [134]
Editorials [4]
Conferences [158]
elearning [13]
Developments in clinical trials and health information technology that will...
Dr Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, USA
Developments in clinical trials and health information technology that will improve targeted therapies for patients ( Dr Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, USA )
1 Jun 2015
Obinutuzumab doubles remission duration in patients with relapsed, indolent non...
Dr Laurie Helen Sehn - BC Cancer Agency, Vancouver, Canada
Obinutuzumab doubles remission duration in patients with relapsed, indolent non-hodgkin lymphoma ( Dr Laurie Helen Sehn - BC Cancer Agency, Vancouver, Canada )
31 May 2015
New targeted treatments for blood cancers: Multiple myeloma, non-Hodgkin...
Dr Merry-Jennifer Markham - University of Florida, Florida, USA
New targeted treatments for blood cancers: Multiple myeloma, non-Hodgkin lymphoma, genomic marker mismatch repair and myelofibrosis ( Dr Merry-Jennifer Markham - University of Florida, Florida, USA )
30 May 2015
New ibrutinib combination regimen shows substantial benefits in relapsed...
Prof Asher Chanan-Khan - Mayo Clinic, Jacksonville, USA
New ibrutinib combination regimen shows substantial benefits in relapsed chronic lymphocytic leukaemia ( Prof Asher Chanan-Khan - Mayo Clinic, Jacksonville, USA )
30 May 2015
Obinutuzumab doubles remission duration in patients with relapsed, indolent non...
Dr Laurie Helen Sehn - BC Cancer Agency, Vancouver, Canada
Obinutuzumab doubles remission duration in patients with relapsed, indolent non-hodgkin lymphoma ( Dr Laurie Helen Sehn - BC Cancer Agency, Vancouver, Canada )
30 May 2015
Pembrolizumab for head and neck cancer
Dr Tanguy Seiwert - University of Chicago, Chicago, USA
Pembrolizumab for head and neck cancer ( Dr Tanguy Seiwert - University of Chicago, Chicago, USA )
29 May 2015
Pembrolizumab shows promising activity against head and neck cancer
Dr Tanguy Seiwert - University of Chicago, Chicago, USA
Pembrolizumab shows promising activity against head and neck cancer ( Dr Tanguy Seiwert - University of Chicago, Chicago, USA )
29 May 2015
Prostate cancer and pharmacokinetics: Expert discussion
Prof Axel S. Merseburger and Prof Romano Danesi
Prostate cancer and pharmacokinetics: Expert discussion ( Prof Axel S. Merseburger and Prof Romano Danesi )
26 May 2015
WIN 2015 hosts 'world class leaders' in personalised therapy
Prof Waun Ki Hong - University of Texas MD Anderson Cancer Center, Houston, USA
WIN 2015 hosts 'world class leaders' in personalised therapy ( Prof Waun Ki Hong - University of Texas MD Anderson Cancer Center, Houston, USA )
13 May 2015
WIN 2015: Oncologists and industry working together for personalised medicine
Prof Razelle Kurzrock - University of California, San Diego, USA
WIN 2015: Oncologists and industry working together for personalised medicine ( Prof Razelle Kurzrock - University of California, San Diego, USA )
13 May 2015
Comment: Metastatic triple-negative breast cancer responds to immunotherapy
Dr Louis Weiner - Lombardi Comprehensive Cancer Center, Washington D.C, USA
Comment: Metastatic triple-negative breast cancer responds to immunotherapy ( Dr Louis Weiner - Lombardi Comprehensive Cancer Center, Washington D.C, USA )
1 May 2015
Real-world targeted treatment based on whole genome sequencing difficult in...
Dr Lorraine Chantrill - Garvan Institute of Medical Research, Darlinghurst...
Real-world targeted treatment based on whole genome sequencing difficult in pancreatic cancer ( Dr Lorraine Chantrill - Garvan Institute of Medical Research, Darlinghurst, Australia )
1 May 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation